LBS 8 specifically detects human urothelium cell lines, tending to recognise the least anaplastic types.
| Inventor | Institute |
|---|---|
| Jenny Southgate ; Ludwik Trejdosiewicz | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| Cat. #: | 151113 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell biology |
| Application: | IHC |
| Target: | Urothelium marker |
| Reactivity: | Human |
| Clone: | LBS 8 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | LBS 8 specifically detects human urothelium cell lines, tending to recognise the least anaplastic types. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | Human urothelial carcinoma -derived RT112 cells. |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | The urothelium is the lining of the ureters, bladder, and urethra. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Trejdosiewicz et al. 1985. J Urol. 133(3):533-8. PMID: 2579255. Monoclonal antibodies to human urothelial cell lines and hybrids: production and characterization. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.